See also this year's filing and all EDGAR filings for this company.
PDF Report 0001571498_2022_Epizyme_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 37427000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
Graph
Absolute values for 0001571498, Epizyme Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 206,043,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 42,849,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,545,000 |
| 3 | remainder_Assets | 38,563,000 |
| 4 | LiabilitiesCurrent | 45,196,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 10,498,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 160,610,996 |
| 9 | ResearchAndDevelopmentExpense | 130,616,771 |
| 10 | remainder_Expenses | 34,234 |
| 11 | remainder_Revenues | 38,872,040 |
| 12 | remainder_NetIncome | -5,442,265 |
| 13 | remainder_ComprehensiveNetIncome | 33,540 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 289,000,000 |
| 1 | Liabilities | 45,196,000 |
| 2 | Expenses | 301,760,001 |
| 3 | Revenues | 38,872,040 |
| 4 | StockholdersEquity | 243,804,000 |
| 5 | NetIncome | -268,330,226 |
| 6 | ComprehensiveNetIncome | -268,313,456 |
| 7 | BaseVar | 340,151,923 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.57 |
| 9 | EconomicCapitalRatio | 2.73 |
Edgar->Model Mapping
Feature Distribution
Change over Time
